Search - tctmd.com

Displaying 341 - 360 of 1203

Sort: Relevancy | Date

News Daily News

ACC/AHA Release Updated Aortic Disease Guideline

Todd Neale

November 02, 2022

News Daily News

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

Todd Neale

November 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

L.A. McKeown

October 13, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

Presentation TCT 2022

How Do I Choose DVTs to Intervene Upon?

Presenter: Jon George

September 19, 2022

Presentation TCT 2022

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

Catheter-Based Management of Infectious Endocarditis

Presenter: Abdallah El Sabbagh

September 19, 2022

Presentation TCT 2022

R Sided Clot in Transit

Presenter: Matthew Finn

September 19, 2022

Presentation TCT 2022

Discussion - Key Takeaways from the RADIANCE Clinical Program

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

FLASH 800 and clinical implications

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Presentation TCT 2022

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

Advertisement

ACC/AHA Release Updated Aortic Disease Guideline

Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT

TCTMD’s Top 10 Most Popular Stories for October 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

TCTMD’s Top 10 Most Popular Stories for September 2022

How Do I Choose DVTs to Intervene Upon?

Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions

Catheter-Based Management of Infectious Endocarditis

R Sided Clot in Transit

Discussion - Key Takeaways from the RADIANCE Clinical Program

FLASH 800 and clinical implications

State-of-the-Art Lecture: Future Device Therapies in PE

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content